microRNA as a marker for early diagnosis of novel coronavirus infection (COVID-19)

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030334

Enrollment

Unknown

Registered

2020-02-28

Start date

2020-02-19

Completion date

Unknown

Last updated

2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:COVID-19 viral PCR

Index test:MicroRNA

Eligibility

Sex/Gender

All

Age

No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age is not limited; 2. Confirmed group:clinical diagnosis is in accordance with the "Notice on issuing a new type of coronavirus pneumonia diagnosis and treatment program (Fifth edition)" on the diagnosis of a new type of coronavirus infection; 3. Suspected group: clinical diagnosis is in accordance with the "Notice on issuing a new type of coronavirus pneumonia diagnosis and treatment program (Fifth edition)" on the diagnosis of suspecting a new type of coronavirus infection.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

Measure	Time frame
SEN, SPE, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactYongxiang Yi

Nanjing Second Hospital

ian0126@126.com+86 13338628626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026